Related references
Note: Only part of the references are listed.Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2
Hui Wen et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2013)
Immunohistochemical Expression of Phospho-mTOR Is Associated With Poor Prognosis in Patients With Gallbladder Adenocarcinoma
Pamela Leal et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β-Independent Mechanism
Ivan Mikaelian et al.
CANCER RESEARCH (2013)
Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
Guanxiong Ding et al.
PLOS ONE (2013)
Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
Seok Joong Yun et al.
KOREAN JOURNAL OF UROLOGY (2013)
TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion
Samy Lamouille et al.
JOURNAL OF CELL SCIENCE (2012)
mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways
Pat Gulhati et al.
CANCER RESEARCH (2011)
Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1
Stephanie C. Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chemotherapy in gallbladder carcinoma
Halima Abahssain et al.
PRESSE MEDICALE (2010)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model
Qi Wu et al.
CANCER RESEARCH (2007)
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways
L. Liu et al.
ONCOGENE (2006)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Laparoscopic cholecystectomy: Its effect on the prognosis of patients with gallbladder cancer
XA de Aretxabala et al.
WORLD JOURNAL OF SURGERY (2004)
Chemotherapy with gemcitabine in patients with gall-bladder carcinoma
J Rudi
ANNALS OF ONCOLOGY (2002)
Share Paper
